TrentRHummelMD

Pediatric Hematology & Oncology • Cincinnati, OH

Associate Professor, Pediatrics, University of Cincinnati College of Medicine

Join to view full profile

Dr. Hummel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hummel's full profile

Already have an account?

Office
3333 Burnet Ave
Ml 7015
Cincinnati, OH 45229
Phone+1 513-636-4266

Fax+1 513-636-3549

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007
Children's Hospital Medical Center of Akron/NEOMEDResidency, Pediatrics, 2001 - 2004
University of Cincinnati College of MedicineClass of 2001

Certifications & Licensure

OH State Medical License 2001 - 2026
IN State Medical License 2022 - 2025
KY State Medical License 2021 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Start of enrollment: 2010 Feb 01
Completed
Phase 1
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors Start of enrollment: 2017 May 08
Suspended
Phase 2
A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) Start of enrollment: 2021 May 24
Recruiting
Phase 1
Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG Start of enrollment: 2017 Apr 04
Recruiting
Not Applicable
Roles: Contact
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer Start of enrollment: 2019 Sep 27
Active, not recruiting
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

6 citations
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.
Mariko DeWire, Margot Lazow, Olivia Campagne, James Leach, Christine Fuller
Neuro-Oncology Advances. 2022-04-16
64 citations
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor co...
Ralph Salloum, Trent R. Hummel, Shiva Senthil Kumar, Kathleen Dorris, Shaoyu Li
Journal of Neuro-Oncology. 2016-06-27
197 citations
Visual outcomes in children with neurofibromatosis type 1–associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Michael Fisher, Michael J. Loguidice, David H. Gutmann, Robert Listernick, Rosalie E. Ferner
Neuro-Oncology. 2012-06-01

Press Mentions

Proton Therapy at Cincinnati Children's Hospital Helps Boy Recover from Brain TumorMay 9th, 2024

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
Society for Neuro-Oncology
Member